Current status and progress of targeted therapy for hepatocellular carcinoma
10.12092/j.issn.1009-2501.2025.02.003
- VernacularTitle:肝细胞癌靶向治疗的现状和进展
- Author:
Zhiwen CHEN
1
;
Longrong WANG
1
;
Lu WANG
1
Author Information
1. 复旦大学附属肿瘤医院肝脏外科,复旦大学上海医学院肿瘤学系,上海 200032
- Publication Type:Journal Article
- Keywords:
hepatocellular carcinoma;
targeted therapies;
immunotherapy;
combination therapy
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2025;30(2):171-182
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma,as a com-mon malignant tumor,remains a serious global health problem.Traditional methods such as surgi-cal resection and chemotherapy have limited ef-fects in improving the prognosis of advanced hepa-tocellular carcinoma.With the deepening of re-search into molecular mechanisms,targeted thera-py has become an important direction for the treat-ment of hepatocellular carcinoma.In this review,we summarize the main targeted drugs and associ-ated therapeutic strategies for hepatocellular carci-noma,aiming to provide references and evidence for future related research.
